Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '25100.00116.09

Profile

Edit
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
URL https://www.biontech.de
Investor Relations URL https://investors.biontech.de/
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 10, 2025
Last Earnings Release Nov. 04, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 02, 2022

Profile

Edit
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
URL https://www.biontech.de
Investor Relations URL https://investors.biontech.de/
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 10, 2025
Last Earnings Release Nov. 04, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 02, 2022
Quickflows